Renal Unit. Catheter Related Bacteraemia Guidelines

Size: px
Start display at page:

Download "Renal Unit. Catheter Related Bacteraemia Guidelines"

Transcription

1 Renal Unit Policy Manager Drew Henderson Policy Group Renal Unit Policy Established 21/01/2014 Policy Review Period/Expiry 21/01/2015 Last Updated 21/01/2014 This policy does apply to Medical/Dental Staff UNCONTROLLED WHEN PRINTED

2 Policy Development, Review and Control Policy Version Control Version Number Purpose/Change Author Date 1.0 Initial Draft Policy Drew Henderson 21/01/ Post AMG discussion Drew Henderson 17/02/2014 Change of duration of Flucloxacillin for MSSA 1.2 Review following IC discussion Drew Henderson 14/03/2014 Changes to document but no major changes in therapy 1.3 Finalised Document for publication Drew Henderson 15/04/2014

3 1. Purpose and Scope The purpose of this document is to standardise the treatment of catheter related bacteraemia in the renal service. Catheter related bacteraemia (CRB) is associated with increased mortality and morbidity in dialysis patients and it is important that treatment as far as possible is standardised to ensure the maximal chance of clearance of infection and reduce morbidity due to distant infection such as osteomyelitis and endocarditis. These guidelines are based on the IDSA guidelines for treatment of catheter related bacteraemia, a recent review in Kidney International, HIS SAB guidelines and are tailored to local antibiotic guidelines. They have been reviewed by NHS Tayside Anti Microbial Group. This guideline acts as guidance and is not rigid and there may be individuals where there requires deviation from standard care (eg last potential access for HD) and in these cases it should documented in the case note why there has been deviation from standard care. This guideline will be referred to when CRBs are reviewed and adherence to the guideline will be audited as part of the Renal Unit s ongoing review of bacteraemias. 2. Abreviations CRB C+S CVC CNS MSSA MRSA TTE TOE CEX BC Catheter related Bacteraemia Culture and Sensitivities Central Venous Catheter Coagulase Negative Staphylococci Methicillin Sensitive Staphylococcus aureus Methicillin Resistant Staphylococcus aureus Trans Thoracic Echocardiogram Transoesphageal Echocardiogram Catheter Exchange Blood Cultures

4 EMPIRIC THERAPY Severe Sepsis Start Sepsis 6 D/W On Call Renal Consultant SEVERE SEPSIS MAP<65mmHG or SBP 40mmHG below normal Lactate>4 New Confusion New Oxgen Requirement New Coagulopathy/ Thrombocytopaenia CLINICAL REVIEW SUSPECTED CRB Fever No Other Source CVC in situ Admit to ward 22 Severe Sepsis? Exit Site Infection Blood Cultures (Central and Peripheral) Temporary Line: Exit Site Infection: (DW On Call Nephrologist first) GIVE Vancomycin IV Dose determined by renal unit protocol If concerns re Grm-ve Gentamicin as per renal unit protocol 48 hour Review Remains Febrile if still in situ Review C+S Afebrile Review C+S as available EXIT SITE ASSESMENT Pus at exit site = Definite Infection 2 of Redness, Tenderness, Swelling = Probable Exit site infection

5 Staph Vanc MIC>2 d/w Microbiology Staph aureus Coagulase Negative Staphylococci Remove Line Catheter Exchange MSSA Flucloxacillin 1g qds MRSA or Penicillin Allergic Vancomycin as per renal unit protocol 2/52 Vancomycin as per protocol Repeat blood cultures at hours TTE +ve TOE: Prosthetic Valve IntraVasc Device +ve repeat BC -ve -ve +ve 2/52 IV Therapy 4-6 weeks IV therapy Refer to local endocarditis guidance Blood Culture Review (including sensitivities and MIC for Staph Sp) Culture Negative No other source Enterococci Catheter Exchange Repeat BC 2/52 Vancomycin as per protocol Inpatient Outpatient 2/52 Amoxicillin 1g IV tds Penicillin Allergic- Vancomycin as per protocol 2/52 Vancomycin as per renal unit protocol Refer to ID/Micro Gram Negative (CEX if difficult access) 14/7 Antibiotics guided by C+S and microbiology Fungal Remove Line Antifungal as directed by Microbiology Blood cultures daily TTE 14/7 antifungal post 1 st sterile culture

6 3. References Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America CID 2009:49 Prevention and management of catheter-related infection in hemodialysis patients Kidney International (2011) 79, Renal Unit Vancomycin Protocol atestreleased&nosaveas=1 HIS Guidance on management of proven or suspected Staphylococcus aureus bacteraemia in adults

MANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION

MANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION MANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION RRCV CMG Renal and Transplant Service 1. Introduction Catheter related blood stream infection (CR-BSI) is a common complication in patients

More information

Haemodialysis central venous catheter-related sepsis management guideline Version 3. NAME M. Letheren Chair Clinical Effectiveness Advisory Group

Haemodialysis central venous catheter-related sepsis management guideline Version 3. NAME M. Letheren Chair Clinical Effectiveness Advisory Group Lancashire Teaching Hospitals NHS Foundation Trust Haemodialysis central venous catheter-related sepsis management guideline Version 3 AUTHOR APPROVED BY DATE AUTH REF. NO NAME REBG/00018/July12 Michael

More information

Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy.

Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy. Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy. Written by: Dr K Gajee, Consultant Microbiologist Date: June 2017 Approved by: Drugs & Therapeutics Committee

More information

The Challenge of Managing Staphylococcus aureus Bacteremia

The Challenge of Managing Staphylococcus aureus Bacteremia The Challenge of Managing Staphylococcus aureus Bacteremia M A R G A R E T G R A Y B S P F C S H P C L I N I C A L P R A C T I C E M A N A G E R N O R T H / I D P H A R M A C I S T A L B E R T A H E A

More information

PATIENT DEMOGRAPHICS. Surname. Given name. Pacific Islander (non-maori) ADMISSION DETAILS

PATIENT DEMOGRAPHICS. Surname. Given name. Pacific Islander (non-maori) ADMISSION DETAILS Reviewer / hospital Date review started PATIENT DEMOGRAPHICS MRN DOB Sex Patient sticky label if available, else enter details here Surname Post-code Given name Australian Aborigine / TSI Middle Eastern

More information

Enhancement of Infection Control for MRSA in Renal Unit

Enhancement of Infection Control for MRSA in Renal Unit Enhancement of Infection Control for MRSA in Renal Unit Ms Ida Yip SNO (Infection Control) Hong Kong East Cluster Hospital 19 August 2011 IC Forum (19-8-2011) 1 MRSA Common Multi Drug Resistant Organisms

More information

Daptomycin in Clinical Practice. Paolo Grossi

Daptomycin in Clinical Practice. Paolo Grossi Clinica delle Malattie Infettive e Tropicali Università degli Studi dell Insubria Ospedale di Circolo e Fondazione Macchi, Varese Second Opinion Infettivologica Centro Nazionale Trapianti, ISS, Roma Daptomycin

More information

Infective Endocarditis Empirical therapy Antibiotic Guidelines. Contents

Infective Endocarditis Empirical therapy Antibiotic Guidelines. Contents Infective Endocarditis Empirical therapy Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Group Additional author(s): as above Authors Division: Division of Clinical

More information

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job

More information

Infections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)

Infections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur) 3 Infections Amenable to OPAT (Nabin Shrestha + Ajay Mathur) Decisions regarding outpatient treatment of infections vary with the institution, the prescribing physician, the individual patient s condition

More information

Hospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia

Hospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia Hospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia Amanda Guth 1 Amy Slenker MD 1,2 1 Department of Infectious Diseases, Lehigh Valley Health Network

More information

Endocardite infectieuse

Endocardite infectieuse Endocardite infectieuse 1. Raccourcir le traitement: jusqu où? 2. Proposer un traitement ambulatoire: à partir de quand? Endocardite infectieuse A B 90 P = 0.014 20 P = 0.0005 % infective endocarditis

More information

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult) VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin

More information

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological

More information

Vancomycin: Class: Antibiotic.

Vancomycin: Class: Antibiotic. Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.

More information

EXECUTIVE SUMMARY. General

EXECUTIVE SUMMARY. General I D S A G U I D E L I N E S Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America Leonard

More information

Panel discussion-aidc 2017 Rapport with the microbiology lab-how it helps your patient

Panel discussion-aidc 2017 Rapport with the microbiology lab-how it helps your patient Panel discussion-aidc 2017 Rapport with the microbiology lab-how it helps your patient Dr Ram Gopalakrishnan Dr S Nandini Moderator Dr V R Yamunadevi Scenario 1 60 year old male patient admitted in ICU

More information

Overview. Clinical Scenario. Endocarditis: Treatment & Prevention. Prophylaxis The Concept. Jeremy D. Young, MD, MPH. Division of Infectious Diseases

Overview. Clinical Scenario. Endocarditis: Treatment & Prevention. Prophylaxis The Concept. Jeremy D. Young, MD, MPH. Division of Infectious Diseases Endocarditis: Treatment & Prevention Jeremy D. Young, MD, MPH Division of Infectious Diseases Clinical Scenario Patient with MVP scheduled to have wisdom teeth extracted. Has systolic murmur with mid-systolic

More information

Daniel C. DeSimone, MD Assistant Professor of Medicine

Daniel C. DeSimone, MD Assistant Professor of Medicine Daniel C. DeSimone, MD Assistant Professor of Medicine Faculty photo will be placed here Desimone.Daniel@mayo.edu 2015 MFMER 3543652-1 Infective Endocarditis Mayo School of Continuous Professional Development

More information

National Surveillance System for Dialysis Centre and Dialysis Associated Diseases

National Surveillance System for Dialysis Centre and Dialysis Associated Diseases National Surveillance System for Dialysis Centre and Dialysis Associated Diseases Dr Richard Fluck Consultant Renal Physician & Clinical Director, Royal Derby Hospital UK RA Vascular Access Survey 2005

More information

Invasive Staphylococcal Infections

Invasive Staphylococcal Infections Invasive Staphylococcal Infections Henry F. Chambers, M.D. Professor of Medicine, UCSF San Francisco General Hospital Disclosures AstraZeneca advisory board Cubist research grant, advisory panel Genentech

More information

A RARE CASE OF SEPTIC SHOCK SECONDARY TO PRIMARY STERNOCLAVICULAR JOINT SEPTIC ARTHRITIS

A RARE CASE OF SEPTIC SHOCK SECONDARY TO PRIMARY STERNOCLAVICULAR JOINT SEPTIC ARTHRITIS A RARE CASE OF SEPTIC SHOCK SECONDARY TO PRIMARY STERNOCLAVICULAR JOINT SEPTIC ARTHRITIS Dr Ehab F. Girgis & Dr Daniel S.Z.M. Boctor National Health Service, UK TAKE HOME MESSAGES 1. SCJ Septic Arthritis

More information

Shunt infections can be best managed medically without removal CONOR MALLUCCI ALDER HEY LIVERPOOL

Shunt infections can be best managed medically without removal CONOR MALLUCCI ALDER HEY LIVERPOOL Shunt infections can be best managed medically without removal CONOR MALLUCCI ALDER HEY LIVERPOOL The issues Shunt infection management has not changed for >20 years Cost to Patient and NHS Standard therapy

More information

Management of severe staphylococcal infections

Management of severe staphylococcal infections Management of severe staphylococcal infections Dilip Nathwani BSAC April 7 th 2009 Ninewells Hospital & Medical School Dundee DD1 9SY Objectives Mortality related to MSSA and MRSA infections Glycopeptides

More information

High Impact Intervention Peripheral intravenous cannula care bundle

High Impact Intervention Peripheral intravenous cannula care bundle High Impact Intervention Peripheral intravenous cannula care bundle Aim To reduce the incidence of peripheral intravenous cannula infections. Introduction The aim of the care bundle, as set out in this

More information

Nephrology. ABC Fax Marie Philipneri Ziyad Al Aly Kamal Amin Mary E. Gellens Bahar Bastani

Nephrology. ABC Fax Marie Philipneri Ziyad Al Aly Kamal Amin Mary E. Gellens Bahar Bastani American Journal of Nephrology Original Article: Patient-Oriented, Translational Research Am J Nephrol 2003;23:202 207 DOI: 10.1159/000071479 Received: April 1, 2003 Accepted: April 9, 2003 Published online:

More information

Protocol for the Management of Neutropenic Sepsis in Adult Patients P

Protocol for the Management of Neutropenic Sepsis in Adult Patients P Protocol for the Management of Neutropenic Sepsis in Adult Patients P Version 2 Date April 2015 Review Date April 2016 Author Rachel Onions Change Approver Acute Oncology Team UHMBT. Version 2. CHANGE

More information

Getting the Point of Injection Safety

Getting the Point of Injection Safety Getting the Point of Injection Safety Barbara Montana, MD, MPH, FACP Medical Director Communicable Disease Service Outbreak of Enterococcus faecalis endocarditis associated with an oral surgery practice

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Staphylococci. What s to be Covered. Clinical Scenario #1

Staphylococci. What s to be Covered. Clinical Scenario #1 Staphylococci Micrococcus, which, when limited in its extent and activity, causes acute suppurative inflammation (phlegmon), produces, when more extensive and intense in its action on the human system,

More information

Consideration of some other specific indications: Bacteremia

Consideration of some other specific indications: Bacteremia European Medicines Agency Workshop on Antibacterials, London 7-8 February 2011 Consideration of some other specific indications: Bacteremia Harald Seifert Institut für Medizinische Mikrobiologie, Immunologie

More information

New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. D. C. Shanson

New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. D. C. Shanson Journal of Antimicrobial Chemotherapy (1998) 42, 292 296 New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis JAC D. C. Shanson Microbiology Department,

More information

Clinical management of Staphylococcus aureus bacteremia an updated proposal of protocol

Clinical management of Staphylococcus aureus bacteremia an updated proposal of protocol Clinical management of Staphylococcus aureus bacteremia an updated proposal of protocol Promotor : Prof. dr. W. Peetermans Second reader : Prof. dr. E. Van Wijngaerden Master s Thesis Internal Medicine

More information

02/10/2017. Major Infectious Complications. Learning Objectives. Modalities. At the end of this session the listener will be able to:

02/10/2017. Major Infectious Complications. Learning Objectives. Modalities. At the end of this session the listener will be able to: Major Infectious Complications Alicia M Neu, MD Chief, Division of Pediatric Nephrology Medical Director, Pediatric Dialysis and Kidney Transplantation The Johns Hopkins University School of Medicine The

More information

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley

More information

Renal patients: IP&C in haemodialysis

Renal patients: IP&C in haemodialysis Renal patients: IP&C in haemodialysis Dr J Richards Formerly, Cons Med Micro & DIPC, N&N Univ. Hosp. NHS Trust Hon Sr. Lecturer, Med School, UEA CHAIR, IFIC Background Healthy kidneys clean the blood

More information

Antibiotic line locks for central venous catheters in adult patients on haemodialysis

Antibiotic line locks for central venous catheters in adult patients on haemodialysis Trust Clinical Guidelines Derby Hospitals NHS Foundation Trust Antibiotic line locks for central venous catheters in adult patients on haemodialysis Introduction Reference No: Microbial colonisation of

More information

VEGETATION NEGATIVE INFECTIVE ENDOCARDITIS A VIEW POINT... Mumbai Dec 2005 Annual scientific sessions

VEGETATION NEGATIVE INFECTIVE ENDOCARDITIS A VIEW POINT... Mumbai Dec 2005 Annual scientific sessions VEGETATION NEGATIVE INFECTIVE ENDOCARDITIS A VIEW POINT... Mumbai Dec 2005 Annual scientific sessions S.Venkatesan,G.Gnanavelu,G.Karthikeyan,V.Jaganathan,R.Alagesan M.Annamalai,S.Shanmugasundaram, S.Geetha,A.Balaguru.G.Anuradha

More information

Focus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba

Focus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba Focus su: Accessi Vascolari dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba Sommario Epidemiologia dell Accesso Vascolare L Accesso Vascolare

More information

Diagnosis and Management of UTI s in Care Home Settings. To Dip or Not to Dip?

Diagnosis and Management of UTI s in Care Home Settings. To Dip or Not to Dip? Diagnosis and Management of UTI s in Care Home Settings To Dip or Not to Dip? 1 Key Summary Points: Treat the patient NOT the urine In people 65 years, asymptomatic bacteriuria is common. Treating does

More information

2018 CNISP HAI Surveillance Case definitions

2018 CNISP HAI Surveillance Case definitions 2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the

More information

Bad Bugs in the Blood!

Bad Bugs in the Blood! Bad Bugs in the Blood! How to Work Up and Treat Bloodstream Infections Sharanjeet Thind M.D. Director of Inpatient Infectious Diseases, VA Medical Center Assistant Professor of Medicine, OUHSC, College

More information

Prosthetic Valve Infective Endocarditis. Tat Yam Department of Infection Southampton University Hospitals NHS TRust

Prosthetic Valve Infective Endocarditis. Tat Yam Department of Infection Southampton University Hospitals NHS TRust Prosthetic Valve Infective Endocarditis Tat Yam Department of Infection Southampton University Hospitals NHS TRust Case History: Episode 1 in MB 73 yr old male, Nigerian PMHx: Hypertension Congestive cardiac

More information

THE INCIDENCE of infections caused by

THE INCIDENCE of infections caused by Vancomycin Prescribing Practices in Hospitalized Chronic Hemodialysis Patients Kevin Green, MD, Gerald Schulman, MD, David W. Haas, MD, William Schaffner, MD, and Erika M.C. D Agata, MD, MPH To determine

More information

Dialysis Event Protocol

Dialysis Event Protocol Dialysis Event Protocol Introduction In 2009, more than 370,000 patients were treated with maintenance hemodialysis in the United States. 1 Hemodialysis patients require a vascular access, which can be

More information

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2 Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics A clinical guideline recommended For use in: All clinical areas where vancomycin is prescribed for Children aged 1 month to 16 years By: All medical, nursing, pharmacy, microbiology and phlebotomy paediatric

More information

Microbiological diagnosis of infective endocarditis; what is new?

Microbiological diagnosis of infective endocarditis; what is new? Microbiological diagnosis of infective endocarditis; what is new? Dr Amani El Kholy, MD Professor of Clinical Pathology (Microbiology), Faculty of Medicine, Cairo University ESC 2017 1 Objectives Lab Diagnostic

More information

Contents. 1. Introduction. J Antimicrob Chemother 2012; 67: doi: /jac/dkr450 Advance Access publication 14 November 2011

Contents. 1. Introduction. J Antimicrob Chemother 2012; 67: doi: /jac/dkr450 Advance Access publication 14 November 2011 J Antimicrob Chemother 2012; 67: 269 289 doi:10.1093/jac/dkr450 Advance Access publication 14 November 2011 Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of

More information

Épidémiologie des endocardites infectieuses à Staphylococcus aureus (Epidemiology of S. aureus endocarditis)

Épidémiologie des endocardites infectieuses à Staphylococcus aureus (Epidemiology of S. aureus endocarditis) Épidémiologie des endocardites infectieuses à Staphylococcus aureus (Epidemiology of S. aureus endocarditis) Lyon, 30 Novembre 2018 Univ.-Prof. Dr. med. Achim J. Kaasch Institut für Medizinische Mikrobiologie

More information

Enhanced EARS-Net Surveillance REPORT FOR 2012 DATA

Enhanced EARS-Net Surveillance REPORT FOR 2012 DATA Enhanced EARS-Net Surveillance REPORT FOR DATA 1 In this report Main results for Proposed changes to the enhanced programme Abbreviations Used Here BSI Bloodstream Infections CVC Central Venous Catheter

More information

Central Venous Access Devices and Infection

Central Venous Access Devices and Infection Central Venous Access Devices and Infection Dr Andrew Daley Microbiology & Infectious Diseases Women s & Children s Health Melbourne Background Types of infection! Local site infection! Blood stream infection!

More information

British Intestinal Failure Alliance (BIFA) Recommendation. Management of Catheter Related Blood Stream Infections (CRBSIs)

British Intestinal Failure Alliance (BIFA) Recommendation. Management of Catheter Related Blood Stream Infections (CRBSIs) British Intestinal Failure Alliance (BIFA) Recommendation Management of Catheter Related Blood Stream Infections (CRBSIs) Authors: Simon Lal, Paul Chadwick, Jeremy Nightingale and the BIFA Committee January

More information

Enhanced EARS-Net Surveillance 2017 First Half

Enhanced EARS-Net Surveillance 2017 First Half 1 Enhanced EARS-Net Surveillance 2017 First Half In this report Main results for 2017, first half Breakdown of factors by organism and resistance subtype Device-association Data quality assessment Key

More information

Cubicin A Guide to Dosing

Cubicin A Guide to Dosing Cubicin A Guide to Dosing Cubicin (Daptomycin) powder for solution for injection or infusion Indications (see SmPC) 1 : Cubicin is indicated for the treatment of the following infections (see sections

More information

BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN

BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN When should I suspect infective endocarditis? Antibiotic regimen Patient care after completion of treatment Prophylactic Regimens Prosthetic Valve

More information

What s to be Covered. Microbiology of staphylococci Epidemiology of S. aureus infections Pathogenesis of S. aureus infections

What s to be Covered. Microbiology of staphylococci Epidemiology of S. aureus infections Pathogenesis of S. aureus infections Staphylococci Micrococcus, which, when limited in its extent and activity, causes acute suppurative inflammation (phlegmon), produces, when more extensive and intense in its action on the human system,

More information

Infective endocarditis

Infective endocarditis Infective endocarditis Today's lecture is about infective endocarditis, the Dr started the lecture by asking what are the most common causative agents of infective endocarditis? 1-Group A streptococci

More information

NHS GRAMPIAN. Healthcare Associated Infection (HAI) Bimonthly Report January 2017

NHS GRAMPIAN. Healthcare Associated Infection (HAI) Bimonthly Report January 2017 NHS GRAMPIAN Healthcare Associated Infection (HAI) Bimonthly Report uary 2017 1. Actions Recommended The Board is requested to note the content of this summary bimonthly HAI Report, as directed by the

More information

Infective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD

Infective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD Infective endocarditis (IE) By Assis. Prof. Nader Alaridah MD, PhD Infective endocarditis (IE) is an inflammation of the endocardium.. inner of the heart muscle & the epithelial lining of heart valves.

More information

Osteomyelitis and Septic Joints; Practical Considerations. Coleen K. Cunningham

Osteomyelitis and Septic Joints; Practical Considerations. Coleen K. Cunningham Osteomyelitis and Septic Joints; Practical Considerations Coleen K. Cunningham Goals/objectives To improve understanding of the diagnosis, treatment, and follow-up of pediatric bone and joint infections

More information

Development of Drugs for Bacteremia

Development of Drugs for Bacteremia Development of Drugs for Bacteremia Charles Knirsch, MD, MPH VP, Clinical Research Pfizer Inc 1 Bacteremia Guidance Issues EMA guidance suggests that bacteremia is not a primary diagnosis but represents

More information

ESPID New Bone and Joint Infection Guidelines

ESPID New Bone and Joint Infection Guidelines ESPID New Bone and Joint Infection Guidelines Theoklis Zaoutis, MD, MSCE Professor of Pediatrics and Epidemiology Perelman School of Medicine at the University of Pennsylvania Chief, Division of Infectious

More information

1 Guidelines for the Management of Candidaemia

1 Guidelines for the Management of Candidaemia 1 Guidelines for the Management of Candidaemia LIVERPOOL CLINICAL LABORATORIES GUIDELINE FOR THE MANAGEMENT OF CANDIDAEMIA IN NON-NEUTROPENIC ADULT PATIENTS AND PROPHYLAXIS/PRE-EMPTIVE TREATMENT IN HIGH

More information

Osteomyelitis Samir S. Shah, MD, MSCE

Osteomyelitis Samir S. Shah, MD, MSCE Osteomyelitis Samir S. Shah, MD, MSCE Professor, Department of Pediatrics University of Cincinnati College of Medicine Director, Division of Hospital Medicine Attending Physician in Infectious Diseases

More information

Blood cultures in ED. Dr Sebastian Chang MBBS FACEM

Blood cultures in ED. Dr Sebastian Chang MBBS FACEM Blood cultures in ED Dr Sebastian Chang MBBS FACEM Why do we care about blood cultures? blood cultures are the most direct method for detecting bacteraemia in patients a positive blood culture: 1. can

More information

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services

More information

Title: Author: Speciality / Division: Directorate:

Title: Author: Speciality / Division: Directorate: Antifungal guidelines for CANDIDIASIS INFECTIONS (Adults) Proven infection: Targeted antifungal therapy should be prescribed for: o Positive cultures from a sterile site with clinical or radiological abnormality

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 October 2006

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 October 2006 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 October 2006 CUBICIN 350 mg (daptomycin), powder for perfusion solution Box of 1 bottle (CIP code: 567 219-3) CUBICIN

More information

03/20/2019. Thank you for the invitation to speak. I have no conflicts of interest

03/20/2019. Thank you for the invitation to speak. I have no conflicts of interest Raj Munshi, MD Annual Dialysis Conference 2019 Thank you for the invitation to speak I have no conflicts of interest Expected remaining lifetime in years of prevalent patients by initial ESRD modality,

More information

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT

Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience

More information

Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections

Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections Version 7.2 PAGL Inclusion Approved at January 2017 PGC APPROVED BY: TRUST REFERENCE: B3/2017 AWP REF: UHL Policies and

More information

An Audit of Staphylococcus aureus Bacteraemia Treatment in a UK District General Hospital

An Audit of Staphylococcus aureus Bacteraemia Treatment in a UK District General Hospital JMID/ 2017; 7 (4):188-193 Journal of Microbiology and Infectious Diseases doi: 10.5799/jmid.369266 RESEARCH ARTICLE An Audit of Staphylococcus aureus Bacteraemia Treatment in a UK District General Hospital

More information

Vancomycin Drug Class 1

Vancomycin Drug Class 1 Drug Class 1 Antibiotic glycopeptide Spectrum 1 Cross Sensitivities / Allergies 1 Refer to product monograph for complete spectrum Gram positive pathogens (e.g., S. aureus, Enterococcus, S. viridans, methicillinresistant

More information

Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults

Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults ORIGINAL ARTICLE INFECTIOUS DISEASES Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults R. B. Saunderson 1, T. Gouliouris

More information

Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients

Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01622.x Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients W. Greiner 1, A.

More information

Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences

Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences ١ ٢ ٣ A 57-year-old man presents with new-onset fever, shortness of breath, lower

More information

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,

More information

Objec&ves. Clinical Presenta&on

Objec&ves. Clinical Presenta&on Michelle A. Barron, MD Associate Professor of Medicine Division of Infectious Diseases University of Colorado Denver Objec&ves Determine who is at risk for invasive candidiasis. Understand whether prophylaxis

More information

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU. Subject: Neutropenic Fever Guideline for Junior Doctors Date of Implementation: January 2010 Date of Review: January 2012 Director Responsible for Implementation and Review: Policy location: Consultant

More information

The Spectrum of Infections in Catheter-Dependent Hemodialysis Patients

The Spectrum of Infections in Catheter-Dependent Hemodialysis Patients Article The Spectrum of Infections in Catheter-Dependent Hemodialysis Yaser Al-Solaiman, Erin Estrada, and Michael Allon Summary Background and objectives Catheter-dependent hemodialysis patients may develop

More information

arguably the greatest risk to human health comes in the form of antibiotic-resistant bacteria. We live in a bacterial world where we will never be

arguably the greatest risk to human health comes in the form of antibiotic-resistant bacteria. We live in a bacterial world where we will never be arguably the greatest risk to human health comes in the form of antibiotic-resistant bacteria. We live in a bacterial world where we will never be able to stay ahead of the mutation curve. A test of our

More information

Clinical profile of high-risk febrile neutropenia in a tertiary care hospital

Clinical profile of high-risk febrile neutropenia in a tertiary care hospital Clinical profile of high-risk febrile neutropenia in a tertiary care hospital Mohan V Bhojaraja 1, Sushma T Kanakalakshmi 2, Mukhyaprana M Prabhu 1, Joseph Thomas 3 1. Department of Medicine, Kasturba

More information

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS

CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS This Care Pathway has been developed by a multidisciplinary team. It

More information

General management of infective endocarditis

General management of infective endocarditis General management of infective endocarditis Team approach in infective endocarditis Gilbert Habib La Timone Hospital Marseille - France Eurovalves Barcelona 2017 The echolab «Heart Team" Infective Endocarditis

More information

Sepsis and Infective Endocarditis

Sepsis and Infective Endocarditis Sepsis and Infective Endocarditis Michal Holub Department of Infectious Diseases First Faculty of Medicine Charles University in Prague and University Military Hospital Bacteremia and Sepsis bacteremia

More information

Supplemental Online Case Discussion: Febrile Neutropenia

Supplemental Online Case Discussion: Febrile Neutropenia Supplemental Online Case Discussion: Febrile Neutropenia Alison C. Young, Fiona J. Collinson St James s Institute of Oncology, St James s University Hospital, Leeds, West Yorkshire, United Kingdom Case

More information

Responders as percent of overall members in each category: Region: New England 50 (58% of 86 members) 19 (51% of 37 members) 3 (33% of 9 members)

Responders as percent of overall members in each category: Region: New England 50 (58% of 86 members) 19 (51% of 37 members) 3 (33% of 9 members) Infectious Diseases Society of America Emerging Infections Network Report for Query: Prosthetic Joint Infections (PJI) in Adults Overall response rate: 556/118 (4.2%) physicians responded from 5/16/12

More information

Bacterial Endocarditis

Bacterial Endocarditis Objectives Bacterial Endocarditis John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota Identify which valves are commonly involved with endocarditis Identify common pathogens

More information

(Max 2 g) = to nearest 250 mg

(Max 2 g) = to nearest 250 mg Appendix 1 (part 1 of 8): Rubric for competency assessment of pharmacists prescribing and managing vancomycin Empiric Dosing Phase Pts Yes No Data Error OP Did the pharmacist document the indication 2

More information

Infective endocarditis

Infective endocarditis Infective endocarditis This is caused by microbial infection of a heart valve (native or prosthetic), the lining of a cardiac chamber or blood vessel, or a congenital anomaly (e.g. septal defect). The

More information

Central Line Associated Blood Stream Infection (CLABSI) William Parker, PharmD, BCPS, CGP, CPh

Central Line Associated Blood Stream Infection (CLABSI) William Parker, PharmD, BCPS, CGP, CPh Central Line Associated Blood Stream Infection (CLABSI) William Parker, PharmD, BCPS, CGP, CPh Learning Objectives for Pharmacists Define Central Line Associated Blood Stream Infections (CLABSIs) and differentiate

More information

Management of Gram-Positive Coccal Bacteremia and Hemodialysis

Management of Gram-Positive Coccal Bacteremia and Hemodialysis In Practice Management of Gram-Positive Coccal Bacteremia and Hemodialysis Lynn N. Fitzgibbons, MD, 1 Darcy L. Puls, MD, 1 Kimberly Mackay, PharmD, 2 and Graeme N. Forrest, MBBS 3 Gram-positive cocci are

More information

Clinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates

Clinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates Clinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates Xuzhuang Shen Beijing Children's Hospital, Capital Medical University,

More information

BSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin

BSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin BSWH Pharmacist Continuing Education 2015 PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin Objectives Define basic pharmacodynamic and pharmacokinetic principles Describe

More information

Bruno Hoen. CHU de Besan ç on Universit é de Franche-Com t

Bruno Hoen. CHU de Besan ç on Universit é de Franche-Com t Bruno Hoen CHU de Besan ç on Universit é de Franche-Com t é SA IE:currentepidem iologic patterns > 30% ofie are SA IE > 30% ofsa IE are healthcare associated > 30% ofpv IE are healthcare associated > 30%

More information

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin Shorr A F, Susla G M, Kollef M H

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin Shorr A F, Susla G M, Kollef M H Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin Shorr A F, Susla G M, Kollef M H Record Status This is a critical abstract of an economic evaluation

More information